Correlation Between Shenzhen Bioeasy and Shanghai Bailian

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shenzhen Bioeasy and Shanghai Bailian at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shenzhen Bioeasy and Shanghai Bailian into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shenzhen Bioeasy Biotechnology and Shanghai Bailian Group, you can compare the effects of market volatilities on Shenzhen Bioeasy and Shanghai Bailian and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shenzhen Bioeasy with a short position of Shanghai Bailian. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shenzhen Bioeasy and Shanghai Bailian.

Diversification Opportunities for Shenzhen Bioeasy and Shanghai Bailian

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Shenzhen and Shanghai is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Shenzhen Bioeasy Biotechnology and Shanghai Bailian Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shanghai Bailian and Shenzhen Bioeasy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shenzhen Bioeasy Biotechnology are associated (or correlated) with Shanghai Bailian. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shanghai Bailian has no effect on the direction of Shenzhen Bioeasy i.e., Shenzhen Bioeasy and Shanghai Bailian go up and down completely randomly.

Pair Corralation between Shenzhen Bioeasy and Shanghai Bailian

Assuming the 90 days trading horizon Shenzhen Bioeasy is expected to generate 5.26 times less return on investment than Shanghai Bailian. In addition to that, Shenzhen Bioeasy is 2.05 times more volatile than Shanghai Bailian Group. It trades about 0.01 of its total potential returns per unit of risk. Shanghai Bailian Group is currently generating about 0.08 per unit of volatility. If you would invest  51.00  in Shanghai Bailian Group on September 12, 2024 and sell it today you would earn a total of  24.00  from holding Shanghai Bailian Group or generate 47.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Shenzhen Bioeasy Biotechnology  vs.  Shanghai Bailian Group

 Performance 
       Timeline  
Shenzhen Bioeasy Bio 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Shenzhen Bioeasy Biotechnology are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shenzhen Bioeasy sustained solid returns over the last few months and may actually be approaching a breakup point.
Shanghai Bailian 

Risk-Adjusted Performance

26 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Bailian Group are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shanghai Bailian sustained solid returns over the last few months and may actually be approaching a breakup point.

Shenzhen Bioeasy and Shanghai Bailian Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shenzhen Bioeasy and Shanghai Bailian

The main advantage of trading using opposite Shenzhen Bioeasy and Shanghai Bailian positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shenzhen Bioeasy position performs unexpectedly, Shanghai Bailian can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanghai Bailian will offset losses from the drop in Shanghai Bailian's long position.
The idea behind Shenzhen Bioeasy Biotechnology and Shanghai Bailian Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments